Mangrove Partners’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-300,000
Closed -$2.94M 430
2021
Q2
$2.94M Hold
300,000
0.3% 73
2021
Q1
$2.91M Buy
+300,000
New +$2.9M 0.29% 98

Other funds holding ISLE

Mangrove Partners's ISLE Position: Q3 2021 in Review

Mangrove Partners sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2021, closing a stake of 300,000 shares — an estimated $2.94M sold.

Mangrove Partners first reported a position in ISLE in Q1 2021 and held it in 2 quarters. The position peaked at $2.94M in Q2 2021. 71 funds tracked by Wall St. Rank hold ISLE as of Q3 2021.

  • Mangrove Partners reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2021 after selling out during the quarter.
  • Mangrove Partners sold 300,000 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2021, an estimated $2.94M.
  • Mangrove Partners first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 2 quarters.
  • Mangrove Partners's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $2.94M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2021.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.